Abstract
The dry period is considered to be a phase when cows are very vulnerable to mastitis and phagocytosis mechanisms are specially important at this moment. The objective of the present trial was to evaluate the influence of dry cow therapy drugs available in the market on the phagocytic function of leukocytes obtained from cow milk. In order to do that, paired milk samples negative in bacteriological examination were submitted to in vitro phagocytosis test, after they were exposed to solutions of the following drugs: anhydrous cephalonium (M1), Gentamicin (M2), Benzylpenicillin procaine associated with Nafcillin and Dihydrostreptomycin (M3) and Cloxacillin benzathine (M4). Mean phagocytosis rates of control samples and of cells submitted to treatments M1 and M3 were, respectively, (58.88% ± 12.04), (64.87% ± 15.36) and (65.14% ± 17.96) there were no differences among these samples, as well as in the comparison with the control group. Mean phagocytosis rate obtained in cells submitted to treatment M4 (46.90% ± 22.08) was lower than that of the control group, and than that of cells submitted to treatments M1 and M3. On the other hand, mean phagocytosis rate of cells submitted to treatment M2 (0.68% ± 1.63) was lower than that observed in the control group, and than that of all other treatments. These results show that the use of drugs available for dry cow therapy may no be totally innocuous for the host. KEY WORDS: Dry period, mastitis, phagocytosis, treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
